Jonathan L. Powell, MD

Successful Crizotinib-Targeted Therapy of Pediatric Unresectable ERC1::ALK Fusion Sarcoma; Unknown Source; (2023).

Sporadic extranodal Rosai-Dorfman-Destombes disease treated with tocilizumab; Pediatric Blood & Cancer; (2022).

Fusion-negative rhabdomyosarcoma with diffuse bony metastases and remarkable chemosensitivity; BMJ Case Reports; (2022).

Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of SMARCB1; JCO Precision Oncology; (2020).

A novel and successful therapeutic approach in the treatment of a patient with simultaneous relapsed Ewing sarcoma and therapy-related acute myeloid leukemia; Pediatric Blood & Cancer; (2020).

Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain-of-function; Blood; (2020).

Topical Amphotericin B in Combination With Standard Therapy for Severe Necrotizing Skin and Soft-Tissue Mucormycosis in an Infant With Bilineal Leukemia; Journal of Pediatric Hematology/Oncology; (2014).

An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma; Bone Marrow Transplantation; (2004).